Score Overview
Explore the 2021 public Archive ranking →
Where AngioDynamics Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ANGO
2010: 20.1% · 2021: 91.4% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 15.54 | — |
1 Year2025-09-26 | $ 10.68 | 45.51% |
5 Years2021-09-28 | $ 23.42 | -33.65% |
10 Years2016-09-28 | $ 17.02 | -8.70% |
20 Years2006-09-28 | $ 20.95 | -25.82% |
All Time2004-05-27 | $ 12.50 | 24.32% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time2004-05-27 |
|---|---|---|---|---|---|---|
| Price | $ 15.54 | $ 10.68 | $ 23.42 | $ 17.02 | $ 20.95 | $ 12.50 |
| Return | — | 45.51% | -33.65% | -8.70% | -25.82% | 24.32% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 313M | -$ 31M | $ 37M |
| 2025 | $ 292M | -$ 33M | $ 55M |
| 2024 | $ 303M | -$ 184M | $ 76M |
| 2023 | $ 338M | -$ 52M | $ 44M |
| 2022 | $ 316M | -$ 26M | $ 28M |
| 2021 | $ 291M | -$ 31M | $ 48M |
| 2020 | $ 264M | -$ 166M | $ 54M |
| 2019 | $ 359M | $ 61M | $ 227M |
| 2018 | $ 344M | $ 16M | $ 75M |
| 2017 | $ 349M | -$ 7M | $ 48M |
| 2016 | $ 353M | -$ 43M | $ 33M |
| 2015 | $ 356M | -$ 3M | $ 20M |
| 2014 | $ 354M | $ 2M | $ 17M |
| 2013 | $ 342M | -$ 1M | $ 23M |
| 2012 | $ 221M | -$ 5M | $ 37M |
| 2011 | $ 215M | $ 8M | $ 131M |
| 2010 | $ 216M | $ 12M | $ 100M |
| 2009 | $ 195M | $ 9M | $ 68M |
| 2008 | $ 166M | $ 10M | $ 78M |
| 2007 | $ 112M | -$ 9M | $ 71M |
| 2006 | $ 78M | $ 6M | $ 89M |
| 2005 | $ 60M | $ 4M | $ 27M |
| IPO2004 | $ 49M | $ 3M | $ 2M |
AngioDynamics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 264M to $ 292M and net income went from -$ 166M to -$ 33M. Revenue increased in 3 of those 5 years; net income in 3.
Across AngioDynamics Inc's full reported history, from 2004 to 2025, revenue grew from $ 49M to $ 292M and net income went from $ 3M to -$ 33M. Revenue increased in 68% of the years measured; net income in 59%.
AngioDynamics Inc currently holds a 20-year HDB Score of 3.3 out of 10. How the HDB Score is calculated.
Membership
Continue ANGO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
